Skip to main content
OpenTrials

Clinical trial condition

Infections

Explore clinical trials studying Infections. Study availability and eligibility vary by location and protocol.

1,542 public trials 228 recruiting studies
Refine in advanced search Browse all conditions

Infections trial results

Completed

A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients

NCT00046176

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +13 more
Locations
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Fountain Valley, California, United States
  • GSK Investigational Site Long Beach, California, United States
  • GSK Investigational Site Los Angeles, California, United States
View all 56 locations
View Trial Details
Completed

New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects

NCT00044577

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +13 more
Locations
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Oakland, California, United States
  • GSK Investigational Site Fort Lauderdale, Florida, United States
  • GSK Investigational Site Fort Lauderdale, Florida, United States
View all 76 locations
View Trial Details
Completed

Incidence of Human Immunodeficiency Virus-1 (HIV-1) Infection in HIV-1 Uninfected High Risk Men Who Have Sex With Men

NCT03310515

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +17 more
Locations
  • GSK Investigational Site Guangzhou, Guangdong, China
  • GSK Investigational Site Shenyang, Liaoning, China
  • GSK Investigational Site Chengdu, Sichuan, China
  • GSK Investigational Site Hangzhou, Zhejiang, China
View Trial Details
Completed

Safety and Efficacy Study of GSK2838232 in Human Immunodeficiency Virus (HIV)-1 Infected Adults

NCT03045861

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Bakersfield, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Los Angeles, California, United States
View all 14 locations
View Trial Details
Completed

Dose Ranging Study of GSK1265744 Plus Nucleoside Reverse Transcriptase Inhibitors for Induction of Human Immunodeficiency Virus-1 (HIV-1) Virologic Suppression Followed by Virologic Suppression Maintenance by GSK1265744 Plus Rilpivirine

NCT01641809

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Little Rock, Arkansas, United States
  • GSK Investigational Site Bakersfield, California, United States
View all 48 locations
View Trial Details
Completed

Evaluating Bactisure Wound Lavage in Orthopedic Wounds

NCT03192124

Conditions
Infection of Total Knee Joint Prosthesis, Infections
Locations
  • LA Orthopedic Institute Los Angeles, California, United States
  • University of Kentucky Orthopedic Spine & Total Joint Service Lexington, Kentucky, United States
  • Norton Orthopaedic & Sports Medicine Specialists Louisville, Kentucky, United States
  • The Cleveland Clinic Cleveland, Ohio, United States
View Trial Details

Related conditions